Godrej Agrovet Limited announced its Q1 FY27 standalone and consolidated unaudited financial results on August 5, 2026. The Board of Directors approved these results, which will be made available on the company’s website. The release details performance across various business segments including Animal Nutrition, Crop Care, Oil Palm, Dairy, and Godrej Foods.
Godrej Agrovet Announces Q1 FY27 Financial Results
Godrej Agrovet Limited (GAVL) has announced its financial results for the first quarter ended June 30, 2026. The Board of Directors of the company, at its meeting held on Wednesday, August 5, 2026, approved the standalone and consolidated unaudited financial results for the quarter.
The company has provided a detailed breakdown of its performance across its key business segments:
HIGHLIGHTS OF FINANCIAL PERFORMANCE (Q1 FY27)
- Consolidated Sales: Rs. 2,852 crore in Q1 FY27, an increase from Rs. 2,603 crore in Q1 FY26.
- Profit Before Tax (excluding non-recurring items): Rs. 172 crore in Q1 FY27, compared to Rs. 188 crore in Q1 FY26.
MANAGING DIRECTOR’S COMMENTS
Mr. Sunil Kataria, Chief Executive Officer & Managing Director, Godrej Agrovet Limited, commented on the resilient performance in Q1 FY27 despite a challenging environment marked by delayed monsoons and geopolitical tensions leading to inflationary pressures. He highlighted robust volume-led growth across most businesses, strong performance in Animal Nutrition and Oil Palm segments, and a positive outlook for the Bangladesh joint venture, ACI Godrej Agrovet.
SEGMENT-WISE BUSINESS HIGHLIGHTS
Animal Nutrition
- Robust topline growth driven by strong demand and improved realizations.
- Cattle feed volumes grew approximately 15% YoY.
- Margin performance strengthened materially, with segment results improving by approximately 36% YoY.
Oil Palm
- Segment revenue driven by improved realizations and higher sales volumes.
- Fresh fruit bunch (FFB) volumes remained broadly flat.
- Segment result increased YoY, supported by enhanced oil extraction efficiency.
Crop Care (Standalone)
- Demand remained muted due to delayed monsoon and slower kharif sowings.
- Segment revenue saw a de-growth due to lower volumes of in-house cotton herbicide.
- New herbicides like Ashitaka (Maize Herbicide) and Takai (Paddy insecticide) gained traction.
- Margin contraction observed due to reduced volumes.
Astec LifeSciences
- Sustained recovery momentum with substantial improvement in EBITDA over Q1FY26.
- Margin expansion across both Enterprise and CDMO categories.
- Revenue saw a marginal de-growth primarily due to a change in product mix.
Dairy
- Healthy revenue growth driven by strong volume growth in value-added products.
- Salience of value-added products improved from 42% in Q1FY26 to 49% in Q1FY27.
- EBITDA was impacted by elevated milk procurement prices and war-led inflation.
Godrej Foods Limited (GFL)
- Branded volume salience grew approximately 6% YoY in Q1FY27.
- Delivered stable revenues and improved quality of earnings.
- EBITDA margins moderated due to higher input costs.
ACI Godrej Agrovet Private Limited, Bangladesh
- Demonstrated strong comeback with robust topline growth driven by volume expansion.
- Profit Before Tax (PBT) increased YoY by 12%.
- Profit after tax declined YoY primarily due to a higher effective tax rate.
A copy of the Media Release is enclosed, and the same has been placed on the company’s website: www.godrejagrovet.com.
Source: BSE
